Regeneron Pharmaceuticals | 489.9200 / -3.27% |
Date/Time | 04/22 / 21:59 |
Chg. / Chg.(%) | -16.5600 / -3.27% |
Bid | 489.9200 / 400 |
Ask | 489.9900 / 100 |
Open | 505.4000 |
Previous Close | 506.4800 |
High | 505.4000 |
Low | 489.2800 |
Volume [USD] | 277,876,846.5154 |
Volume [Units] | 853,299 |
Price fixings | 3826 |
ISIN | US75886F1075 |
Security | REGN |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 489.9200 | ![]() |
853,299 |
IEX | 496.16 | ![]() |
55,758 |
Cboe US | 490.00 | ![]() |
41,629 |
TradeGate | 408.900 | ![]() |
724 |
Moscow | 37,401.00 | ![]() |
239 |
Stuttgart | 411.700 | ![]() |
220 |
Xetra | 417.50 | ![]() |
115 |
London Inter.. | 497.97 | ![]() |
74 |
München | 416.75 | ![]() |
15 |
gettex | 409.950 | ![]() |
11 |
Frankfurt | 413.4000 | ![]() |
4 |
Hamburg | 418.00 | ![]() |
0 |
Hannover | 418.00 | ![]() |
0 |
Düsseldorf | 413.40 | ![]() |
0 |
Berlin | 416.55 | ![]() |
0 |
Vienna Globa.. | 417.35 | ![]() |
0 |
Lang & Schwa.. | 405.65 | ![]() |
|
Mexico | 10,046.00 | ![]() |
127 |
News
- ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
13:51 - GlobeNewswire - Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell
04/19/2021 / 14:00 - GlobeNewswire - Intellia Therapeutics Names Georgia Keresty, Ph.D., M.P.H., to Board of Directors
04/12/2021 / 13:30 - GlobeNewswire - Roche: Antibody cocktail reduces symptomatic COVID infections by 81%
04/12/2021 / 07:25 - TeleTrader - Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting
04/07/2021 / 15:00 - GlobeNewswire